Complete Androgen Insensitivity Syndrome in a Child Raised as Female: A Case Report of Diagnosis and Multidisciplinary Management
Keywords:
46, XY DSD, CAIS, AMBIGUOUSAbstract
Abstract.
Background Disorders of sex development (DSD) constitute a heterogeneous group of congenital conditions affecting chromosomal, gonadal, or anatomical sex differentiation. Complete Androgen Insensitivity Syndrome (CAIS), a leading cause of 46,XY DSD, results from pathogenic variants in the androgen receptor (AR) gene that abolish androgen signaling, thereby producing a female phenotype despite a 46,XY karyotype. Delayed Diagnosis carries significant clinical, psychological, and ethical implications.
Case Presentation: We describe a 9-year-7-month-old child with a 46, XY karyotype, raised female since birth, who first presented at 2 weeks of age with ambiguous genitalia. Examination showed hypertrophied labia majora, a narrow vaginal introitus, a 1 cm phallus, and bilaterally palpable gonads (left labial, right inguinal). Hormonal testing revealed markedly elevated testosterone (618.63 ng/dL) alongside prepubertal gonadotropins, indicating end-organ androgen resistance. Pelvic MRI demonstrated bilateral undescended testes and absent Müllerian structures. Genetic testing identified a pathogenic missense variant, AR c.2567G>A (p.Arg856His), confirming CAIS. Management involved a multidisciplinary approach, including parental counseling, pubertal surveillance, planned post-pubertal gonadectomy, and psychological support.
Discussion: This case highlights the value of a systematic diagnostic pathway for 46, XY DSD that integrates phenotyping, hormonal assessment, imaging, and molecular confirmation. Timely molecular Diagnosis supports appropriate gender identity guidance, optimal gonadectomy timing, and long-term hormone and malignancy surveillance planning.
Conclusions: CAIS should be suspected in 46, XY individuals with female phenotype and palpable gonads. A structured multidisciplinary evaluation is essential for Diagnosis and long-term care.
References
References
1. Kumar I, Prakash A, Aggarwal P,Chowdhary S, Verma A. Disorders of sexual development: structured radiological reporting and practical approach. Abdominal Radiology. 2024. 49:523-534. Doi: https://doi.org/10.1007/s00261-023-04066-x
2. Batista RL, Costa EMF, Rodrigues AS, et al. Androgen insensitivity syndrome: a review. Arch Endocrinol Metab. 2018;62(3):227–235. doi:10.20945/2359-3997000000031
3. Warne GL: Complete androgen insensitivity syndrome: a guide for parents and patients . In: Disorders of Sex Development. Hutson J, Warne G, Grover S (ed): Springer, Berlin; 2012. 291-298. 10.1007/978-3-642-22964-0_27
4. Fava Spessoto LC, Avelino Silveira JS, Abularach AM, et al. Rare case of complete androgen insensitivity syndrome. Cureus. 2024;16:e54550. doi:10.7759/cureus.54550
5. Bennecke E, Strandqvist A, De Vries A, Kreukels BPC. Psychological support for individuals with differences of sex development (DSD). J Psychosom Res. 2024 Apr;179:111636. doi: 10.1016/j.jpsychores.2024.111636. Epub 2024 Mar 1. PMID: 38507969.
6. Wang C and Tian Q. Molecular pathogenesis, diagnosis, and management challenges in complete androgen insensitivity syndrome. Front. Endocrinol. 2025. 16:1600343. doi: 10.3389/fendo.2025.1600343
7. Jurrayyan NAM, Jurayyan RNA, Haboob AAN, et al. Radiologic Imaging in Patients with 46 XY, Disorders of Sex Development (DSD): A 25 Years’ Experience from a Major Teaching Hospital. Scholars Journal of Applied Medical Sciences (SJAMS). 2014. 2(6B):2063-2067
8. Chen Z, Li P, Lyu Y, et al. Molecular genetics and general management of androgen insensitivity syndrome. Intractable Rare Dis Res. 2023 May;12(2):71-77. doi: 10.5582/irdr.2023.01024. PMID: 37287652; PMCID: PMC10242393.
9. Kappy MS, Allen DB, Geffner ME, eds. Pediatric Practice: Endocrinology. New York: McGraw-Hill; 2010.
How to Cite
Issue
Section
License
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
